Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa dose-ranging study of Yishen Huazhuo Granules in membranous nephropathy
ChiCTR-IID-17013318Phase 2Completed
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jun 2017
- Countries
- 1
01
Overview
Phase 2 trial of Yishen Huazhuo Granules in membranous glomerulonephritis (MGN) (3 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Change from baseline in 24-hour urine protein. Started Jun 2017; status: completed.
02
Drugs
Yishen Huazhuo Granules
03
Conditions
membranous glomerulonephritis (MGN)
Beyond the preview
Go deeper on ChiCTR-IID-17013318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IID-17013318.